Abraxis Oncology
Abraxis Oncology is fully committed to the development and commercialization of products that offer innovative and fresh possibilities for oncologists and the patients they treat. Our team of clinical experts strives to quickly and safely bring breakthrough discoveries from the bench to the bedside. Abraxis Oncology has pioneered the use of nanotechnology and is committed to bringing this novel technology to the oncology clinic. We have successfully developed the first and only oncology product that utilizes our proprietary nab™ technology. This novel drug delivery system has the potential to make effective chemotherapeutics better. The future of cancer care lies in the continued discovery of new compounds that improve efficacy and minimize toxicity. The pursuit of next-generation chemotherapies is, and will continue to be, the impassioned mission of Abraxis Oncology.
200 Somerset Corporate Blvd.
Bridgewater,, NJ 08807 USA
908.393.8220
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||